Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TYMS | P04818 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14042821 | 0.82 | ALOX15 (0.35) | ALOX15TDP1 | |
| SCHEMBL3055211 | 0.71 | AKR1B1 (0.32) | ALOX15TDP1 | |
| SCHEMBL10926488 | 0.69 | MEN1 (0.39) | ALOX15TDP1ALDH1A1CYP2A6CYP2B6 | |
| SCHEMBL3993249 | 0.69 | TDP1 (0.59) | ALOX15TDP1TYMSALDH1A1 | |
| Phthalic Anhydride SCHEMBL220 | 0.67 | TDP1 (1.00) | ALOX15TDP1TYMSALDH1A1 | |
| Phthalic Anhydride SCHEMBL29356227 | 0.67 | TDP1 (1.00) | ALOX15TDP1TYMSALDH1A1 | |
| Phthalic Anhydride SCHEMBL380499 | 0.67 | TDP1 (1.00) | ALOX15TDP1TYMSALDH1A1 | |
| SCHEMBL9674007 | 0.67 | MEN1 (0.37) | ALOX15TDP1ALDH1A1ESR1ESR2 | |
| SCHEMBL10024777 | 0.65 | MEN1 (0.67) | ALOX15TDP1ALDH1A1 | |
| Phthalic Anhydride SCHEMBL21824259 | 0.65 | TDP1 (0.93) | ALOX15TDP1TYMSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250260054-A1 | ELECTRIC STORAGE DEVICE | Prime Planet Energy & Solutions, Inc. (JP) | 2025-08-14 | — | — | US | claimed |
| CN-118271570-A | Preparation method of organic phosphine-terminated non-conjugated oxygen-enriched fluorescent polymer, and product and application thereof | 浙江大学 | 2024-07-02 | — | — | CN | claimed |
| CN-117624982-B | Water-based antistatic coating material and preparation method thereof | 苏州市星辰新材料集团有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118005811-A | Responsive room-temperature phosphorescent polymer material, and preparation method and application thereof | 中国科学院化学研究所 | 2024-05-10 | — | — | CN | claimed |
| US-20240128492-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM ION SECONDARY CELL | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2024-04-18 | — | — | US | claimed |
| CN-117624982-A | Water-based antistatic coating material and preparation method thereof | 苏州市星辰新材料集团有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117447760-A | Conductive expandable composite microsphere and preparation method and application thereof | 江南大学 | 2024-01-26 | — | — | CN | claimed |
| US-20210336268-A1 | METHOD AND SYSTEM FOR FUNCTIONAL CONDUCTIVE POLYMER INITIATED CATHODE ELECTROLYTE INTERFACE FOR SILICON ANODE-BASED LITHIUM ION BATTERIES | ENEVATE CORPORATION | 2021-10-28 | — | — | US | claimed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-104402901-B | The synthetic method of a kind of DBTPD | CHONGQING INSTITUTE OF GREEN AND INTELLIGENT TECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2016-05-11 | — | — | CN | claimed |
| US-5532328-A | Process for the preparation of a polymer | DSM N.V. (NL) | 1996-07-02 | — | — | US | claimed |
| EP-0633903-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1995-01-18 | — | — | EP | claimed |
| WO-1994017120-A1 | PROCESS FOR THE PREPARATION OF A POLYMER FROM A HETEROCYCLIC MONOMER | DSM N.V. (NL) | 1994-08-04 | — | — | WO | claimed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4685146-A1 | COMPOUND FOR ORGANIC PHOTOVOLTAIC DEVICES, AND ORGANIC PHOTOVOLTAIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE EACH CONTAINING SAME | Duk San Neolux Co., Ltd. (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-12522612-B2 | PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications | BIOTHERYX INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-4661591-A | Preparation of 4,5-dihydrodithieno[3,4-b:3',4'-e]azepine-5,9-dione | BASF AKTIENGESELLSCHAFT (DE) | 1987-04-28 | — | — | US | disclosed |
| US-4259476-A | ANTITUMOR ACTIVITY AGAINST MURINE P388 LEUKEMIA IN MICE | UNIVERSITY OF ROCHESTER, THE | 1981-03-31 | — | — | US | disclosed |
| WO-1980002112-A1 | NOVEL HETEROCYCLIC ANTHRACYCLINE COMPOUNDS | NEWMAN H (US) | 1980-10-16 | — | — | WO | disclosed |
| EP-0017469-A1 | Novel heterocyclic anthracycline compounds, processes for their preparation and pharmaceutical compositions containing them | Kende, Andrew Steven (US) | 1980-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | TST, SELENOI, SELE | ALOX15 4376/4885TDP1 1223/4885TYMS 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.